Cargando…

The potential risks of delaying the second vaccine dose during the SARS-CoV-2 pandemic

Detalles Bibliográficos
Autores principales:	Humphreys, I R, Godkin, A J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989192/ https://www.ncbi.nlm.nih.gov/pubmed/33677593 http://dx.doi.org/10.1093/qjmed/hcab046

Ejemplares similares

Ethical and policy considerations for COVID-19 vaccination modalities: delayed second dose, fractional dose, mixed vaccines
por: Wolff, Jonathan, et al.
Publicado: (2021)

Delayed skin reactions after the second dose of mRNA vaccines against SARS-CoV-2
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

SARS-CoV-2 and EBV; the cost of a second mitochondrial “whammy”?
por: Nunn, Alistair V.W., et al.
Publicado: (2021)

Pediatric SARS-CoV-2 Infection: Risk Factors for Severity Comparing the First and Second Wave of the Pandemic
por: Natarajan, Ramesh, et al.
Publicado: (2023)

The prospects for the SARS‐CoV‐2 pandemic in Africa
por: Quaresima, Virginia, et al.
Publicado: (2020)

Is a third SARS‐CoV‐2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients?
por: Spyridonidis, Alexandros
Publicado: (2022)

The potential of developing a protective peptide‐based vaccines against SARS‐CoV‐2
por: Shalash, Ahmed O., et al.
Publicado: (2022)

Evolutionary medical insights into the SARS-CoV-2 pandemic
por: Crespi, Bernard
Publicado: (2020)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Is there a post-SARS-CoV-2 vaccination dementia?
por: Fiorini, Ana C., et al.
Publicado: (2022)

Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks
por: Billington, John, et al.
Publicado: (2020)

Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
por: Pawelec, Graham, et al.
Publicado: (2021)

Multicomponent vaccines to fight SARS-CoV-2 variants of concern
por: Cassone, Antonio, et al.
Publicado: (2021)

The challenge of emerging SARS-CoV-2 mutants to vaccine development
por: Li, Rong, et al.
Publicado: (2021)

SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
por: Antonopoulou, Tania, et al.
Publicado: (2022)

Questioning the justification for a fourth SARS-CoV-2 vaccine
por: Calderon-Margalit, Ronit, et al.
Publicado: (2022)

Is the second dose of vaccination useful in previously SARS-CoV-2-infected healthcare workers?
por: Pean De Ponfilly, G., et al.
Publicado: (2021)

Graves’ disease following administration of second dose of SARS-CoV-2 vaccine
por: Goblirsch, Timothy James, et al.
Publicado: (2021)

Effects of Second Dose of SARS-CoV-2 Vaccination on Household Transmission, England
por: Zaidi, Asad, et al.
Publicado: (2023)

Gastrointestinal endoscopy operation—A potential transmission risk for SARS-CoV-2
por: Tan, Caixia, et al.
Publicado: (2020)

Africa’s contribution to the science of the COVID-19/SARS-CoV-2 pandemic
por: Kana, Musa Abubakar, et al.
Publicado: (2021)

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
por: Salvatori, Giovanni, et al.
Publicado: (2020)

Pregnant people deserve the protection offered by SARS-CoV-2 vaccines
por: Maykin, Melanie M., et al.
Publicado: (2021)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
por: Cevik, Muge, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for immune-comprised patients: More is required
por: Li, Hui, et al.
Publicado: (2021)

SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface
por: Sharun, Khan, et al.
Publicado: (2021)

A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses
por: Pettini, Elena, et al.
Publicado: (2022)

Analysis of Host Cell Receptor GRP78 for Potential Natural Reservoirs of SARS-CoV-2
por: Sirakov, I., et al.
Publicado: (2020)

The SARS-CoV-2 pandemic puts the spotlight on gender inequality in clinical research
por: Søgaard, Mette, et al.
Publicado: (2021)

Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Skin rashes after SARS‐CoV‐2 vaccine: which relationship, if any?
por: Patruno, Cataldo, et al.
Publicado: (2021)

Vaccine against SARS-CoV-2 in previously infected health care workers
por: Parisi, Saverio Giuseppe
Publicado: (2021)

Increasing SARS-CoV-2 vaccination rates among Black people in Canada
por: Eissa, Azza, et al.
Publicado: (2021)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2021)

A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated
por: Hoehl, Sebastian, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in the context of original antigenic sin
por: Petráš, Marek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mielskauv2gokio6p5u7erplm6